KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to $29.5 million.

  • LifeMD's Cost of Revenue rose 1075.78% to $29.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.6 million, marking a year-over-year increase of 1649.92%. This contributed to the annual value of $103.0 million for FY2024, which is 3475.22% up from last year.
  • Per LifeMD's latest filing, its Cost of Revenue stood at $29.5 million for Q3 2025, which was up 1075.78% from $29.1 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Cost of Revenue ranged from a high of $29.5 million in Q3 2025 and a low of $16.7 million during Q1 2023
  • For the 5-year period, LifeMD's Cost of Revenue averaged around $22.5 million, with its median value being $21.8 million (2022).
  • Per our database at Business Quant, LifeMD's Cost of Revenue soared by 57886.13% in 2021 and then crashed by 2369.8% in 2023.
  • LifeMD's Cost of Revenue (Quarter) stood at $21.2 million in 2021, then decreased by 17.61% to $17.4 million in 2022, then increased by 16.9% to $20.4 million in 2023, then rose by 26.81% to $25.9 million in 2024, then grew by 14.0% to $29.5 million in 2025.
  • Its last three reported values are $29.5 million in Q3 2025, $29.1 million for Q2 2025, and $29.2 million during Q1 2025.